Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Care | Study protocol

Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Prescribing, monitoring and administration of medicines in care homes could be improved. A cluster randomised controlled trial (RCT) is ongoing to evaluate the effectiveness of an independent prescribing pharmacist assuming responsibility for medicines management in care homes compared to usual care.

Aims and Objectives

To conduct a mixed-methods process evaluation of the RCT, in line with Medical Research Council (MRC) process evaluation guidance, to inform interpretation of main trial findings and if the service is found to be effective and efficient, to inform subsequent implementation.

Objectives

1.
To describe the intervention as delivered in terms of quality, quantity, adaptations and variations across triads and time.
 
2.
To explore the effects of individual intervention components on the primary outcomes.
 
3.
To investigate the mechanisms of impact.
 
4.
To describe the perceived effectiveness of relevant intervention components [including pharmacist independent prescriber (PIP) training and care home staff training] from participant [general practitioner (GP), care home, PIP and resident/relative] perspectives.
 
5.
To describe the characteristics of GP, care home, PIP and resident participants to assess reach.
 
6.
To estimate the extent to which intervention delivery is normalised among the intervention healthcare professionals and related practice staff.
 

Methods

A mix of quantitative (surveys, record reviews) and qualitative (interviews) approaches will be used to collect data on the extent of the delivery of detailed tasks required to implement the new service, to collect data to confirm the mechanism of impact as hypothesised in the logic model, to collect explanatory process and final outcome data, and data on contextual factors which could have facilitated or hindered effective and efficient delivery of the service.

Discussion

Recruitment is ongoing and the trial should complete in early 2020. The systematic and comprehensive approach that is being adopted will ensure data is captured on all aspects of the study, and allow a full understanding of the implementation of the service and the RCT findings. With so many interrelated factors involved it is important that a process evaluation is undertaken to enable us to identify which elements of the service were deemed to be effective, explain any differences seen, and identify enablers, barriers and future adaptions.

Trial registration

Date registered: 15 December 2017.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alldred D, Raynor D, Hughes C, Barber N, Chen T, Spoor P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2013;2:CD009095. Alldred D, Raynor D, Hughes C, Barber N, Chen T, Spoor P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2013;2:CD009095.
2.
go back to reference Department of Health: Implementation resurce for the use of medicines in care homes for older people. DH Alert [online] 2010. Department of Health: Implementation resurce for the use of medicines in care homes for older people. DH Alert [online] 2010.
9.
go back to reference Barber N, Alldred D, Raynor D, et al. The care homes use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care. 2009;18:341–6.CrossRef Barber N, Alldred D, Raynor D, et al. The care homes use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care. 2009;18:341–6.CrossRef
10.
go back to reference Bond CM, Lane K, Poland F, et al. Care homes independent pharmacist prescribing study (CHIPPS): GP views on the potential role for pharmacist independent prescribers within care homes. Int J Pharm Pract. 2016;24(s2):6. Bond CM, Lane K, Poland F, et al. Care homes independent pharmacist prescribing study (CHIPPS): GP views on the potential role for pharmacist independent prescribers within care homes. Int J Pharm Pract. 2016;24(s2):6.
13.
go back to reference Bond C, Holland R, Alldred D, et al. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials. 2020;21:103.CrossRef Bond C, Holland R, Alldred D, et al. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials. 2020;21:103.CrossRef
14.
go back to reference Moore G, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. London: MRC Population Health Science Research Network; 2014. Moore G, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. London: MRC Population Health Science Research Network; 2014.
17.
go back to reference May C, Finch T, Mair F, et al. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res. 2007;7:148.CrossRef May C, Finch T, Mair F, et al. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res. 2007;7:148.CrossRef
18.
go back to reference May C, Mair FS, Finch T, et al. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009;4:29.CrossRef May C, Mair FS, Finch T, et al. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009;4:29.CrossRef
Metadata
Title
Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study
Publication date
01-12-2020
Keyword
Care
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04264-8

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue